baber/WOPTO huggingface dataset:
Patent FI-962854-A0 (FI)
Inventor: COMELLINI ENRICO
IPC: H02J13/00
Filed: 1996-07-15
Abstract: A system for the remote control of the electricity distribution network and the telereading of the electricity, gas, water and other services meters of the customers connected to the same network. More specifically a system which uses centralized and distributed intelligence to manage the information and carrier currents at relatively high frequencies over the wires of the electricity networks to transmit the information. The carrier current system is implemented according to an original method, which, unlike the traditional one, does not utilize high frequency traps and by passes, at the network nodes. This method allows the use of the power distribution network without the expensive changes required by the traditional solution. This result is obtained by forecasting the messages over the Medium Voltage (MV) and the Low Voltage (LV) radial networks as they are configurated for the distribution of the electricity and by properly addressing the various substations and the customer meters. Because the MV and LV electricity network configuration is subject to change as a consequence of intentionaly made switching operations or as a consequence of automatic tripping of the switchgears following a fault, the method of properly addressing and routing the messages to their final destinations requires that the state of the network is very frequently updated. This function is performed by the system subject of this invention and the updating of the state of the network, a very important information in itself, has to be seen as an added value for the system.
Patent FI-963339-A0 (FI)
Inventor: NODA ISAO
IPC: D04H1/42
Filed: 1996-08-27
Abstract: The present invention comprises processes for preparing biodegradable fibrils from one or more biodegradable homopolymeric or copolymeric resins, said process comprising: a) forming a liquid resin mixture by melting or solvating the resin or resins; and b) introducing the liquid resin mixture to a flow of a gaseous substance. The present invention further comprises biodegradable fibrils made according to the processes of the present invention. The invention further comprises nonwoven fabrics comprising biodegradable fibrils. The invention further comprises disposable absorbent articles comprising a water-permeable topsheet, an absorbent core, and a water-impermeable backsheet, wherein the topsheet comprises a nonwoven substrate comprising biodegradable fibrils. The invention further comprises disposable articles comprising biodegradable fibrils.
Patent FI-964033-A0 (FI)
Inventor: SELAWRY HELENA P
IPC: A61K35/12
Filed: 1996-10-08
Abstract: The present invention describes a method of treating a disease that results from a deficiency of a biological factor which includes administering to a mammal Sertoli cells and cells that produce the biological factor. In particular, the present invention describes a method of treating diabetes mellitus by transplanting pancreatic islet of Langerhans cells in conjunction with Sertoli cells to create an immunologically privileged site. A method of creating an immunologically privileged site in a mammal for cellular transplants is further described by the present invention. A pharmaceutical composition comprising Sertoli cells and cells that produce a biological factor is also provided.
Patent FI-964082-A0 (FI)
Inventor: HODSON CHRISTOPHER DOUGLAS
IPC: E01C5/06
Filed: 1996-10-11
Abstract: PCT No. PCT/GB95/00840 Sec. 371 Date Dec. 6, 1996 Sec. 102(e) Date Dec. 6, 1996 PCT Filed Apr. 12, 1995 PCT Pub. No. WO95/28523 PCT Pub. Date Oct. 26, 1995A surfacing block (1) has upper and lower surfaces (2, 7) bounded by walls (5) extending between the surfaces (2, 7). The surfaces (2, 7) are of a generally cruciform shape having four arms (4) each of which extend in a direction substantially parallel to the lower surface (7) and substantially perpendicular to two of the other arms (4) of the block. The block (1) has around the boundary of its surface projections (8) and/or recesses (9) for interlocking engagement with recesses and/or projections of a neighbouring block. The shape of the block helps to improve the resistance to movement of the block when laid with similar blocks.
Patent FI-971132-A0 (FI)
Inventor: HITZIGER HUBERT
IPC: F02F1/38
Filed: 1997-03-18
Abstract: An internal combustion engine of the known type has a 4-valve cylinder head with a central injector valve. To cool the cylinder head floor, coolant flows via a total of eight inlets into individual outer cooling chambers in the cylinder head before passing via cast channels into an inner cooling chamber surrounding the injector valve. From there, the coolant passes directly to an outlet. This internal combustion engine is improved by the feature that a cooling chamber between the cylinder head floor (25) and an intermediate partition (17) includes an outter uninterrupted annular chamber (12) which is connected via straight cooling bores (13) with an injector valve cooling chamber (14) in the middle of the cylinder head floor (25), and by the presence of additional cooling channels (19) which connect at least one outlet valve cooling chamber (20) with the annular chamber (12) and injector valve cooling chamber (14). This design facilitates effective cooling of the cylinder head in those areas subjected to thermal stress and is also advantageous in structural terms. In addition, the assembly process entailed by the invention is optimised by the fact that cylinder head, intermediate housing, cylinder pipe, piston and connecting rod form a single assembly unit which can be pre-assembled. These components can thus be assembled at one site by mechanics especially trained for that task and then fitted as a pre-assembled unit in the engine.
Patent AP-9600861-A0 (AP)
Title: Immunotherapeutic agent and its use.
Inventor: ROOK GRAHAM ARTHUR WILLIAM
IPC: A61K35/74
Filed: 1995-03-29
Abstract: The invention relates to the use of antigenic and/or immunoregulatory material derived from mycobacterium vaccae for delaying or preventing the growth or spread of tumors.
Patent IL-61360-A0 (IL)
Title: Manufacture of a certain dibenzazepine derivative and intermediates used therefor
IPC: C07D223/26
Filed: 1980-10-28
Abstract: The invention relates to a process for the manufacture of the known 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine of the formula III which is characterized in that, for example, 5-cyano-5H-dibenz[b,f]azepine of the formula I is nitrated to form 5-cyano-10-nitro-5H-dibenz[b,f]azepine of the formula II, this is subjected to hydrolysis, then reduction, then the reduction product contained in the reaction mixture is subjected to hydrolysis and the end product of the formula III is isolated in pure form. The process is illustrated by the following reaction scheme:   <IMAGE>    <IMAGE> +TR  <IMAGE>  The invention relates also to new intermediates produced in these reactions.
Patent IL-68140-A0 (IL)
Title: Optically active phenoxybenzoic acid derivatives,their preparation and their use as herbicides
IPC: A01N37/12
Filed: 1983-03-16
Abstract: 1. Dextrorotatory enantiomers of phenoxybenzoic acid derivatives of the formula  see diagramm : EP0089538,P10,F5  in which X represents hydrogen or chlorine.
Patent IL-92010-A0 (IL)
Title: Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07D417/06
Filed: 1989-10-16
Abstract: A compound of the formula : <CHEM>  wherein R<1> is alkyl, ar(lower)alkyl which may have suitable substituent(s), or heterocyclic(lower)alkyl,  R<2> is hydrogen or an acyl group, and R<3> is carboxy(lower)alkyl, protected carboxy(lower)alkyl, carboxyaryl or protected carboxyaryl,  and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
Patent AU-PM388794-A0 (AU)
Title: Beadcrete
IPC: E01F9/524
Filed: 1994-02-16
Abstract: A surface finish for application to a substrate comprising vertical, horizontal or sloping surfaces of a structure or object, the surface finish comprising: a matrix formed from a combination of at least a cementitous material, water and glass beads of either the same size or a blend of at least two different sizes and an adhesive.
Patent AU-PM562794-A0 (AU)
Title: New and improved liquid treating apparatus
IPC: C02F1/50
Filed: 1994-05-13
Abstract: PCT No. PCT/AU95/00280 Sec. 371 Date Nov. 12, 1996 Sec. 102(e) Date Nov. 12, 1996 PCT Filed May 15, 1995 PCT Pub. No. WO95/31404 PCT Pub. Date Nov. 23, 1995The invention provides water sterilizing apparatus (10) adapted to employ the process of heavy metal sterilization and including a body (11) defining a chamber (12) formed with spaced inlet and outlet openings (13, 14) whereby water may be caused to flow through the chamber, a silver anode (15) to coact with at least one cathode (16) spacedly mounted in said chamber for release of Ag+ ions to the flow of water therebetween; electric circuit means (17) including power cell means (18) associated with said body and connected to said electrodes (15, 16); an on/off switch (20) in said circuit means (17) normally disposed inoperatively so that the circuit is open when water is not entering said chamber (12) at said inlet opening (13), and a switch-actuating valve assembly (21) mounted movably adjacent said inlet opening, said valve assembly being normally urged in biased manner to a position in which it closes the inlet opening (13) but adapted to be moved against said bias by water caused to flow through said inlet opening whereby said water enters and passes through said chamber and out said outlet opening, and the parts being so made and arranged that movement of said switch-actuating valve assembly (21) to open the inlet opening (13) causes said normally-open switch (20) to be closed to complete the circuit.
Patent FI-20002890-A0 (FI)
Inventor: TOURUNEN ARI
IPC: H04W28/06
Filed: 2000-12-29
Abstract: A method of configuring a compression method for a terminal in a mobile system. The mobile system comprises a terminal for which characteristics parameters are specified comprising at least the compression methods supported by the terminal, and a radio network, in which a functional entity is configured for specifying a compression method to a radio bearer. The use of a compression method on the radio bearers of the terminal is specified on the basis of the characteristics parameters transmitted by the terminal. The user of the terminal updates the parameters specifying the compression methods of the terminal, the characteristics parameters of the terminal being modified in the terminal in accordance with this update, and the modified characteristics parameters are transmitted to a function comprised by the radio network. The modified characteristics parameters are used to configure the use of a compression method for each simultaneous radio bearer of the terminal. <IMAGE>
Patent IL-107425-A0 (IL)
Title: Methods and compositions for generating disinfectants during the ozonization of water
IPC: A62D3/00
Filed: 1993-10-27
Abstract: Methods and compositions for generating stable, residual disinfectants during the ozonization of water, comprising the carrying out the ozonization of water in the presence of bromide ions and an effective amount of a hypobromite ion scavenger possessing imide and/or amide functionality that preferentially converts hypobromite ions to biocidal, ozone-stable derivatives thereof to thereby suppress the catalytic decomposition reaction of ozone with hypobromite ions. The methods and compositions of the present invention are useful for water disinfection and algae control, generally.
Patent IL-113421-A0 (IL)
Title: Method for measuring and extending the service life of metal components
IPC: F02B77/08
Filed: 1995-04-19
Abstract: Improved methods for managing a population of metal components subject to fatigue failure are provided. The residual compressive stress in the critical surfaces of such components, especially in areas of high stress concentration, are measured non-destructively using x-ray diffraction techniques. The measured residual compressive stress is used as a management criteria. A component having a residual compressive stress greater than a predetermined value can be returned to service. However, once the measured residual compressive stress of a component galls below the predetermined value, it can either be removed permanently from service, or it can be reworked to increase its residual compressive stress and then returned to service. Additionally, by measuring the residual compressive stress of an individual component, the remaining service life of that individual component can be estimated. These methods for management of populations of such metal components allow for increasing the service life of the components in a safe and effective manner.
Patent IL-123489-A0 (IL)
Title: Acoustic device
IPC: H04R1/02
Filed: 1996-09-02
Abstract: Acoustic device (81) including a member (2) extending transversely of its thickness and capable of sustaining bending waves at least over an intendedly consequentially acoustically active area of the transverse extent of said member, the member (2) having, by reason of orderly design methodology disclosed and claimed, a distribution of resonant modes of its natural bending wave vibration at least over said area that is dependent on values of particular parameters of said members, including geometrical configuration and directional bending stiffness(es), which values have been selected to predetermine said distribution of natural resonant modes being consonant with required achievable acoustic action of said member for operation of said device over a desired operative acoustic frequency range.
Patent IL-127315-A0 (IL)
Title: Membrane incorporation of texaphyrins
IPC: A61K31/40
Filed: 1997-06-04
Abstract: Compositions having a texaphyrin-lipophilic molecule conjugate loaded into a biological vesicle and methods for imaging, diagnosis and treatment using the loaded vesicle are provided. For example, liposomes or red blood cells loaded with a paramagnetic texaphyrin-lipophilic molecule conjugate have utility as a blood pool contrast agent, facilitating the enhancement of normal tissues, magnetic resonance angiography, and marking areas of damaged endothelium by their egress through fenestrations or damaged portions of the blood vascular system. Liposomes or cells loaded with a photosensitive texaphyrin-lipophilic molecule conjugate can be photolysed, allowing for a photodynamic therapy effect at the site of lysis. Availability of red blood cells loaded with a photosensitive texaphyrin-lipophilic molecule conjugate provides a method for delivering a photodynamic therapeutic agent to a desired site with a high concentration of oxygen. By presenting the agent in this way, it is expected that a patient will experience less toxicity.        00000
Patent IL-133308-A0 (IL)
Title: Automatic weapon
IPC: F41A9/41
Filed: 1998-06-03
Abstract: An automatic weapon has a housing 1 with a movable spring-mounted barrel assembly 6 having a barrel 7 and a receiver 8. The receiver 8 has a spring-mounted bolt support 24 with a bolt 27, a buffer mechanism 32 and a firing pin mechanism 33 having a movable firing hammer 36 which interacts with the bolt support 24. The housing 1 has a trigger mechanism 50 with a firing trigger 52, a sear 43 with a spring-mounted pawl 18 interacting with the trigger 52 and the firing hammer 36, and a movable tripper 53 with cams (56, 67) interacting with the spring-mounted pawl 48 and the trigger 52. A device angularly displaces the barrel assembly 6 relative to the housing 1 and a muzzle attachment device 13 has expanding chambers with intercrossing cavities.
Patent IL-150359-A0 (IL)
Title: Use of chemotherapeutic agents
Inventor: SCHULZ HANS-HERRMANN
IPC: A61F13/20
Filed: 2000-12-22
Abstract: The use of active agent(s) (A) selected from 4-oxo-quinoline-3-carboxylic acid derivatives (including naphthyridine or quinolizine analogs) (I) or (II) for topical and/or local treatment or prophylaxis of bacterial diseases in humans or animals is new.  The use of one or more active agent(s) (A) selected from 4-oxo-quinoline-3-carboxylic acid derivatives (including naphthyridine or quinolizine analogs) of formula (I) or (II) and their hydrates, acid addition salts, carboxylate salts, enantiomers, diastereomers, racemates or mixtures, optionally together with auxiliaries, is claimed for the preparation of medicaments for topical and/or local treatment or prophylaxis of bacterial diseases in humans or animals. The use of ciprofloxacin for the treatment of eye or ear diseases is excluded.  A  =  CH, C(halogen), C(Me), C(CN), C(OMe), C(OCHF2) or N;  R1  =  1-5C alkyl, 2-5C alkenyl, 2-fluoroethyl, cycloalkyl, bicycloalkyl, 2-fluorocyclopropyl, 1-oxetan-3-yl, NHMe, optionally substituted phenyl or pyridyl;  or A + R1  =  C-O-CH2-CH(Me)-;  R2  =  H or 1-3C alkyl (optionally substituted by OH, halo or NH2);  R3  =  H, halo, Me, NH2 or NHNH2;  R4  =  H, halo or NH2;  R5, R'2  =  optionally substituted mono-, bi- or tricyclic alicyclic system (optionally containing double bond(s)) or mono-, bi- or tricyclic aromatic system (both optionally containing heteroatom(s));  R'1  =  H or 1-3C alkyl. An Independent claim is included for gel formulations containing one or more (A).
Patent IL-153190-A0 (IL)
Title: Method for controlling the integrity of a nanofiltration or reverse osmosis module, or module system
IPC: B01D65/10
Filed: 2001-06-01
Abstract: The invention concerns a method for controlling a nanofiltration or reverse osmosis module system designed for treating a supply fluid or for detecting living micro-organism leaks, each module comprising nanofiltration or reverse osmosis membranes and joints connecting said membranes, including steps which consist in: selecting in the supply fluid a dissolved compound present in significant amount but normally highly retained by the membranes; measuring the concentration value of said compound in a downstream zone of a module of said system; comparing said measured value with a reference value; and recognising the existence of a fault in said zone of the system when said measured value is higher than the reference value.
Patent IL-155801-A0 (IL)
Title: A nucleic acid sequence encoding human testis specific kinases
IPC: G01N33/50
Filed: 2001-11-09
Abstract: The present invention relates to a family of testis specific kinases (the tssk family), nucleic acid sequences encoding those kinases and antibodies against the kinases. The invention is further directed to the use of thise kinases as targets for isolating specific inhibitors or anagonists of tssk kinase activity. Such inhibitors are anticipated to have use as contraceptive agents.
Patent IL-165540-A0 (IL)
Title: A printer with cartridge storing machine readable ink
IPC: B41L27/10
Filed: 2004-12-02
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent IL-194499-A0 (IL)
Title: Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application
Filed: 2008-10-02
Abstract: Disclosed is a pharmaceutical composition for the prevention and correction of age-related disorders of cellular and humoral immunity and having an immunogeroprotective effect. The pharmaceutical composition includes a peptide glutamyl-aspartyl-proline with general formula H-Glu-Asp-Pro-OH sequence 1 [SEQ ID NO:1]. The pharmaceutical composition can be in the form suitable for parenteral administration. Also disclosed is a method of prevention and/or correction of age-related disorders of cellular and humoral immunity by stimulating the processes of lymphocytes proliferation and differentiation, such method consisting in the administration to a patient of a pharmaceutical composition containing an effective amount of peptide glutamyl-aspartyl-proline with general formula: H-Glu-Asp-Pro-OH sequence 1 [SEQ ID NO:1] in the dose of 0.01-100 μg/kg of body weight as an active base at least once a day during a period necessary for attaining a therapeutic effect.
Patent IL-200539-A0 (IL)
Title: Method and apparatus for the surface modification of flat substrates
Filed: 2009-08-20
Abstract: The invention in general relates to the single-sided wet chemical surface modification as in particular the coating of flat substrates. In particular, the present invention relates to a method as well as to an apparatus for the coating of substrates in the course of the production of thin film solar cells or modules made from glass, metal, or plastic with metallic compounds such as i.e. cadmium sulphide or zinc sulphide.
Patent IL-205413-A0 (IL)
Title: Method and apparatus for controlling operation of an access terminal in a communication system
IPC: H04W36/38
Filed: 2010-04-28
Abstract: A novel and improved method and apparatus provide for controlling an operation of an access terminal while processing a signal from an access point in a communication system. Various aspects of the invention provide for an access terminal to disable a handoff process when its demodulator or decoder is operating to demodulate or decode a control message received from an access point. The operation of the access terminal is controlled in a manner that prevents terminating prematurely the demodulation and decoding process of a control signal by a handoff process. As a result, the access terminal may continue operating in a normal wake up/ sleep cycle period while conserving its battery power.
Patent RO-125328-A0 (RO)
Title: Vertical axis wind turbine with mobile shutters
Inventor: CĂLIN SILVIU CĂTĂLIN
IPC: F03D3/02
Filed: 2009-06-25
Abstract: The invention relates to a vertical axis wind turbine with mobile shutters meant to generate electric current. According to the invention, the turbine has a rotor (1) comprising some blades (2) and which is mounted on a support (3), whereon, in its turn, there are mounted some mobile shutters (4), linked to one another by an articulated mechanism (5) put into motion by an electric motor (6) by means of a cable (7).